Research Article
Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer
Table 3
Association between PRDX expression and OS in GC patients with different HER2 expression status.
| PRDXs | HER2 status | Cases | Low | High | HR (95% CI) | value |
| PRDX1 | Negative | 532 | 266 | 266 | 0.62 (0.49–0.77) | <0.001 | Positive | 344 | 172 | 172 | 0.75 (0.58–0.98) | 0.031 |
| PRDX2 | Negative | 532 | 266 | 266 | 0.66 (0.52–0.82) | <0.001 | Positive | 344 | 172 | 172 | 0.56 (0.43–0.73) | <0.001 |
| PRDX3 | Negative | 532 | 266 | 266 | 0.51 (0.40–0.64) | <0.001 | Positive | 344 | 172 | 172 | 0.97 (0.75–1.25) | 0.809 |
| PRDX4 | Negative | 532 | 266 | 266 | 0.63 (0.51–0.79) | <0.001 | Positive | 344 | 172 | 172 | 0.72 (0.56–0.94) | 0.014 |
| PRDX5 | Negative | 429 | 214 | 215 | 0.89 (0.68–1.16) | 0.390 | Positive | 202 | 101 | 101 | 0.77 (0.53–1.12) | 0.171 |
| PRDX6 | Negative | 532 | 266 | 266 | 0.81 (0.65–1.01) | 0.061 | Positive | 344 | 172 | 172 | 1.05 (0.81–1.35) | 0.737 |
|
|